Impact Factor
3.87
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.53
2,150 total citations
h5-index
49
h5 depth signal
Cited share
82.6%
530 of 642
Total citations
2,150
Citation footprint
Metric signal
3.23
External metric anchor
Self-citation
6.9%
148 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
1,278
China
1,191
Germany
179
Japan
169
Australia
153
Citing Fields of Research
Ophthalmology
3,227
Cell Biology
389
Epithelial Barriers
345
Noncoding RNA
184
Immunology
161
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
14,219
Articles tracked across the journal lifetime
Indexed publication set
642
530 cited publications
Last 12 months
495
41.3 publications/month
Open access share
26.1%
129 OA publications in the last year
Leading citing country
United States
1,278 citing publications
Leading citing field
Ophthalmology
3,227 citing publications
Latest tracked publication
19 October 2026
10 recent records available
Coverage & Indexing History
v4n3,Sept. 1965-
v4n3,Sept. 1965-
Active Coverage
Active Coverage
Research Focus & Classification
Indexed Subjects
Ophthalmology
Broad Categories
Ophthalmology
MeSH Descriptors
Ophthalmology
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1016/j.exer.2026.111285
Open DOI
Otx2 directly regulates tbx3 expression during early eye formation
02
03
DOI 10.1016/j.exer.2026.111286
Open DOI
Corneal fibrosis: Mechanistic networks, stage-dependent therapeutic windows, and regenerative strategies
04
DOI 10.1016/j.exer.2026.111280
Open DOI
Effects of exogenous relaxin on dry eye in an experimental Sjögren's disease (SS) mouse model
05
06
07
08
DOI 10.1016/j.exer.2026.111276
Open DOI
tRF-Glu-CTC-005 promotes pathological retinal neovascularization via ACSL4 in microvascular endothelial cells
09
DOI 10.1016/j.exer.2026.111278
Open DOI
Advances in long-acting ocular therapies for dry eye disease: Delivery systems, formulations, and clinical perspectives
10
DOI 10.1016/j.exer.2026.111284
Open DOI
Novel laboratory technique for immunofluorescent detection of intraocular ranibizumab in a rat model
Bibliographical & Catalog Notes
Supplements accompany some vols.
Also issued online.
Vol. 50, no. 1 (JAN 1990)19901002 Notice published Printed on acid-free paper